USD 5.8 Billion
Ankylosing Spondylitis Market Size, Share, Growth Analysis, By Treatment(Medication, therapy, and surgery), By Application(Juveniles and adults), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2220 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
61
|Figures:
75
Ankylosing Spondylitis Market Insights
Ankylosing Spondylitis Market size was valued at USD 6.32 Billion in 2022 and is poised to grow from USD 6.88 Billion in 2023 to USD 13.72 Billion by 2031, at a CAGR of 9.0% during the forecast period (2024-2031).
The global ankylosing spondylitis market, a chronic inflammatory disease primarily affecting the spine and joints, is experiencing significant growth. The market is driven by several factors that contribute to the diagnosis, treatment, and management of the condition. One of the key drivers is the increasing prevalence of ankylosing spondylitis worldwide. The rising awareness about the disease, along with improved diagnostic techniques, has led to early detection and diagnosis. Additionally, advancements in medical research and the development of novel therapeutic options have expanded the treatment options available to patients, driving the growth of the market. Furthermore, the growing aging population, which is more prone to developing ankylosing spondylitis, contributes to the market growth. The prevalence of the disease is higher among men, further influencing the market dynamics.
The availability of effective medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), tumor necrosis factor (TNF) inhibitors, and interleukin inhibitors, has significantly improved the quality of life for patients, leading to increased market demand. However, the global ankylosing spondylitis market also faces challenges. One of the major challenges is the underdiagnosis and misdiagnosis of the condition due to its non-specific symptoms and slow disease progression. This results in delayed treatment and management, impacting patient outcomes. Additionally, the high cost of certain biologic therapies and limited access to healthcare in certain regions pose challenges for patients in accessing appropriate treatments. Furthermore, the lack of a permanent cure for ankylosing spondylitis and the need for long-term disease management present ongoing challenges in the market.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Adults
Fastest Growth
Adults
Growth Rate
9.0% CAGR
Global Ankylosing Spondylitis Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Ankylosing Spondylitis Market Segmental Analysis
The global ankylosing spondylitis market is segmented on the basis of treatment, application, and region. By treatment, the market is segmented into medication, therapy, and surgery. By application, the market is segmented into juveniles and adults. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis By Treatment
The global ankylosing spondylitis market can be segmented by treatment into medication, therapy, and surgery. Each segment represents different approaches to managing the symptoms and progression of ankylosing spondylitis. The dominant segment in the global ankylosing spondylitis market is medication. Medications play a crucial role in the treatment of ankylosing spondylitis, aiming to reduce pain, inflammation, and stiffness, and improve overall joint function. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed as a first-line treatment to alleviate symptoms and control inflammation. Additionally, biologic therapies, such as tumor necrosis factor (TNF) inhibitors and interleukin inhibitors, are highly effective in managing the disease by targeting specific molecules involved in the inflammatory process. Medication-based treatment options remain the primary choice for most patients with ankylosing spondylitis.
The fastest-growing segment in the global ankylosing spondylitis market is therapy. Therapy encompasses various non-pharmacological approaches to managing ankylosing spondylitis, including physical therapy, exercise programs, and lifestyle modifications. These interventions focus on improving mobility, maintaining proper posture, and strengthening the muscles surrounding the affected joints. Therapy plays a crucial role in managing pain, maintaining joint flexibility, and improving overall quality of life for individuals with ankylosing spondylitis. The growing recognition of the benefits of therapy in reducing symptoms and preventing disease progression is driving its rapid growth in the market.
Analysis By Application
The global ankylosing spondylitis market can be segmented by application into juveniles and adults, representing different age groups affected by the disease. The dominant segment in the global ankylosing spondylitis market is adults. Ankylosing spondylitis primarily affects adults, typically emerging between the ages of 20 and 40. The majority of diagnosed cases and treatment interventions are focused on adults. This can be attributed to the fact that the disease tends to manifest and progress during adulthood, leading to significant functional impairment and reduced quality of life if left untreated. The dominant position of the adult segment in the market is a reflection of the higher prevalence and greater emphasis on diagnosing and managing ankylosing spondylitis in adult patients.
The fastest-growing segment in the global ankylosing spondylitis market is juveniles. Although ankylosing spondylitis is commonly associated with adults, there is a growing recognition of the disease's occurrence in younger individuals, including adolescents and children. Juvenile ankylosing spondylitis refers to the manifestation of the disease before the age of 16. This segment is witnessing growth due to improved awareness, early detection, and better diagnostic techniques. Early diagnosis and appropriate treatment interventions are crucial in managing juvenile ankylosing spondylitis, as it allows for better disease control, symptom management, and prevention of long-term complications. The increasing understanding of ankylosing spondylitis in juveniles and the need for tailored treatment approaches contribute to the rapid growth of this segment in the market.
Global Ankylosing Spondylitis Market By Application
To get detailed analysis on other segments, Request For Free Sample Report
Ankylosing Spondylitis Market Regional Insights
The dominant region in the global ankylosing spondylitis market is North America. This can be attributed to several factors, including a higher prevalence of ankylosing spondylitis in the region, well-established healthcare infrastructure, and a greater awareness and diagnosis of the disease. North America is home to a significant number of diagnosed cases and has a well-established market for ankylosing spondylitis treatments. The region's dominant position is further supported by the presence of key market players, advanced research and development facilities, and a strong focus on patient care and disease management.
The fastest-growing region in the global ankylosing spondylitis market is expected to be Asia Pacific. This can be attributed to several factors, including the increasing awareness about ankylosing spondylitis, improving healthcare infrastructure, and rising healthcare expenditure in countries like China, India, and Japan. Additionally, the increasing prevalence of ankylosing spondylitis in the region, driven by factors such as genetic predisposition and changing lifestyles, is contributing to the market growth. Furthermore, the growing availability of advanced diagnostic techniques and treatment options, along with the rising adoption of biologic therapies, is fueling the growth of the market in the Asia Pacific region.
Global Ankylosing Spondylitis Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Ankylosing Spondylitis Market Dynamics
Drivers
Advancements in Medical Research and Treatment Options
- Advances in medical research have led to a better understanding of ankylosing spondylitis, its underlying mechanisms, and potential treatment approaches. The development of targeted therapies, such as tumor necrosis factor (TNF) inhibitors and interleukin inhibitors, has significantly improved the management of ankylosing spondylitis. The availability of effective medications and evolving treatment guidelines contribute to the growth of the market.
Rising Healthcare Expenditure and Infrastructure
- Increasing healthcare expenditure, along with the improvement of healthcare infrastructure in various regions, plays a significant role in driving the market. Enhanced access to healthcare services, including specialised clinics, diagnostic facilities, and treatment centres, improves the diagnosis and management of ankylosing spondylitis, leading to increased market growth.
Restraints
Long-Term Disease Management Challenges
- Ankylosing spondylitis requires long-term management and continuous treatment. Compliance with medication regimens, adherence to lifestyle modifications, and regular follow-ups are essential for effective disease control. The challenges associated with long-term disease management, including patient adherence, lifestyle adjustments, and disease monitoring, can impact the market growth.
Lack of Curative Treatment
- Ankylosing spondylitis currently lacks a permanent cure. Although available treatments can help manage symptoms and slow disease progression, the absence of a curative treatment option remains a significant restraint. Research efforts to develop novel therapies and potential disease-modifying treatments are ongoing to address this challenge.
Request Free Customization of this report to help us to meet your business objectives.
Ankylosing Spondylitis Market Competitive Landscape
The competitive landscape of the global ankylosing spondylitis market is characterised by intense competition among various players in the industry. The market is composed of pharmaceutical companies, biotechnology firms, and medical device manufacturers, all striving to develop innovative treatments and solutions for ankylosing spondylitis. These players compete based on factors such as product efficacy, safety, pricing, research and development capabilities, and market presence. Market players focus on extensive research and development efforts to develop novel medications and therapies that can effectively manage ankylosing spondylitis. They invest in clinical trials, collaborative research partnerships, and scientific advancements to stay at the forefront of innovation. Additionally, companies engage in strategic collaborations and licensing agreements to enhance their product portfolios and expand their market reach. Moreover, market players actively participate in awareness campaigns, patient education initiatives, and advocacy programs to raise disease awareness and promote early diagnosis. They work closely with healthcare professionals, patient organisations, and key stakeholders to improve the understanding of ankylosing spondylitis and provide support to patients. The competitive landscape also includes the development of advanced diagnostic tools and medical devices that aid in the diagnosis and monitoring of ankylosing spondylitis. Companies invest in technologies such as imaging techniques, genetic testing, and biomarker identification to enhance diagnostic accuracy and disease monitoring. In addition to pharmaceutical and biotechnology companies, other stakeholders such as healthcare providers, research institutions, and academic organisations contribute to the competitive landscape through their involvement in clinical trials, research collaborations, and the development of evidence-based treatment guidelines.
Top Player’s Company Profile
- AbbVie Inc. - US
- Pfizer Inc. - US
- Novartis International AG - Switzerland
- Amgen Inc. - US
- Johnson & Johnson - US
- Eli Lilly and Company - US
- UCB S.A. - Belgium
- Merck & Co., Inc. - US
- Bristol Myers Squibb Company - US
- GlaxoSmithKline plc - UK
- Boehringer Ingelheim GmbH - Germany
- Takeda Pharmaceutical Company Limited - Japan
- Biogen Inc. - US
- Celgene Corporation - US
- Regeneron Pharmaceuticals, Inc. - US
- Astellas Pharma Inc. - Japan
- Sandoz International GmbH (Novartis AG) - Switzerland
- Mylan N.V. - US
- Teva Pharmaceutical Industries Ltd. - Israel
- Sanofi - France
Recent Developments
- In January 2023, AbbVie announced that the FDA has approved Rinvoq (upadacitinib) for the treatment of adults with moderately to severely active ankylosing spondylitis (AS). Rinvoq is a JAK inhibitor, a type of biologic drug that works by blocking the activity of certain proteins involved in inflammation.
Ankylosing Spondylitis Key Market Trends
- Focus on Early Diagnosis and Treatment: There is a growing emphasis on early diagnosis and treatment of ankylosing spondylitis. Early detection allows for timely intervention and the initiation of appropriate treatments to control inflammation, manage symptoms, and prevent disease progression. Healthcare providers and patient advocacy organisations are promoting awareness campaigns and educational initiatives to facilitate early diagnosis and improve patient outcomes.
- Personalised Treatment Approaches: The understanding that ankylosing spondylitis is a heterogeneous disease has led to a shift towards personalised treatment approaches. Healthcare providers are increasingly tailoring treatment plans based on individual patient characteristics, including disease severity, comorbidities, and treatment response. Personalised medicine aims to optimise outcomes by selecting the most suitable treatment options for each patient.
Ankylosing Spondylitis Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global ankylosing spondylitis market analysis, North America holds a dominant position in the global ankylosing spondylitis market due to higher prevalence, well-established healthcare systems, and market presence. Asia Pacific, on the other hand, represents the fastest-growing region, driven by increasing awareness, improving healthcare infrastructure, and a rising number of diagnosed cases. The global ankylosing spondylitis market is experiencing significant growth and transformation driven by various factors. The increasing prevalence of ankylosing spondylitis, coupled with improved diagnostic techniques and awareness, has led to early detection and diagnosis of the disease. Advancements in medical research and the development of targeted therapies, such as biologic medications, have expanded the treatment options available to patients, resulting in improved symptom management and enhanced quality of life. There is a growing focus on personalised treatment approaches, early intervention, and disease monitoring, which aim to optimise patient outcomes and prevent disease progression. The integration of digital health solutions and the involvement of patient advocacy organisations further contribute to the market's advancement. However, challenges such as underdiagnosis, high treatment costs, and the absence of a permanent cure remain significant restraints. Addressing these challenges through increased awareness, improved access to care, and ongoing research efforts will be crucial for the continued growth and better management of ankylosing spondylitis. Overall, the global ankylosing spondylitis market presents promising opportunities for healthcare providers, pharmaceutical companies, and other stakeholders to improve patient care and contribute to the ongoing advancement of treatment options.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 6.32 Billion |
| Market size value in 2031 | USD 13.72 Billion |
| Growth Rate | 9.0% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Ankylosing Spondylitis Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Ankylosing Spondylitis Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Ankylosing Spondylitis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Ankylosing Spondylitis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Ankylosing Spondylitis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Ankylosing Spondylitis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
